| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000038860 |
| Receipt No. | R000044233 |
| Scientific Title | Research on mechanism and prevention for the side effect of herb licorice |
| Date of disclosure of the study information | 2019/12/28 |
| Last modified on | 2019/12/10 (Ver. 1) |
| Basic information | ||
| Public title | Research on the side effects of herb licorice | |
| Acronym | Study on side effects of licorice | |
| Scientific Title | Research on mechanism and prevention for the side effect of herb licorice | |
| Scientific Title:Acronym | Research on mechanism and prevention for the side effect of licorice | |
| Region |
|
|
| Condition | |||
| Condition | all | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The evaluation of mechanism of pseudoaldosteronism caused by licorice |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Measurement of blood and urine samples |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient taking any kamopmedicnes | |||
| Key exclusion criteria | none | |||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, Chiba University | ||||||
| Division name | Deptartment of Japanese-Oriental (Kampo) Medicine, | ||||||
| Zip code | 260-8670 | ||||||
| Address | 1-8-1 Inohana, Chuo-ku, Chiba city | ||||||
| TEL | +81-432262984 | ||||||
| tnamiki@faculty.chiba-u.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medicine, Chiba University | ||||||
| Division name | Deptartment of Japanese-Oriental (Kampo) Medicine, | ||||||
| Zip code | 260-8670 | ||||||
| Address | 1-8-1 Inohana, Chuo-ku, Chiba city | ||||||
| TEL | +81-432262984 | ||||||
| Homepage URL | |||||||
| tnamiki@faculty.chiba-u.jp | |||||||
| Sponsor | |
| Institute | Deptartment of Japanese-Oriental (Kampo) Medicine,Graduate School of Medicine, Chiba University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Developmnt |
| Organization | |
| Division | |
| Category of Funding Organization | Government offices of other countries |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Chiba University |
| Address | 1-8-1 Inohana, Chuo-ku, Chiba city |
| Tel | 0432227171 |
| crc-kikaku@ML.chiba-u.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Using the information of age and sex as well as serum potassium levels obtained by ordinary blood tests as reference data, We measure glycyrrhizic acid metabolites in the blood and urine of patients taking Kampo medicine. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044233 |